Management of Day-1 Neonate with Platelet Count 45,000/µL

Step 1 - Classify the Severity and Urgency

Step 2 - Immediate Investigations

Bloods

• Repeat platelet count to confirm (in-line with history, rule out clumping artifact)
• FBC (look for anemia, infection markers)
• Coagulation screen (PT, APTT, fibrinogen) - to rule out concurrent DIC
• Blood film - platelet morphology, red cell fragments
• Maternal platelet count - if low, suggests maternal ITP; if normal with low fetal platelets, suspect FNAIT

For FNAIT/NAIT workup

• Maternal and paternal HPA typing (HPA-1 to -5)
• Maternal anti-HPA antibody screen (HPA-1a is the most common cause in Caucasians; HPA-4 in Asians)
• Cranial ultrasound within 24 hours - to screen for intracranial hemorrhage (ICH occurs in 10-20% of NAIT cases)

Infection screen

• Blood culture, CRP, CBC differential
• Consider TORCH (CMV, toxoplasmosis, rubella, HSV) in early-onset cases with no obvious immune cause
• Sepsis is a common cause of early neonatal thrombocytopenia

Step 3 - Determine the Cause

• Most common: Placental insufficiency (IUGR, maternal hypertension/pre-eclampsia, diabetes)
• Immune: FNAIT (most serious), maternal ITP/SLE
• Congenital: TAR (thrombocytopenia absent radii), CAMT (congenital amegakaryocytic thrombocytopenia)
• Infection: congenital viral infections (CMV, rubella, HSV)
• Chromosomal: trisomy 13, 18, 21

Step 4 - Platelet Transfusion Thresholds (2024 Guidelines)

• If term + no bleeding + no FNAIT suspected - Do NOT transfuse yet; monitor closely (counts may continue to fall over first few days)
• If preterm on respiratory support or sepsis - Transfuse (above threshold of 30,000-50,000)
• If FNAIT suspected (especially term infant) - Transfuse to keep count >30,000 (prophylactic), or >50,000 if active bleeding
• If any active bleeding - Transfuse immediately

Key evidence update: The PlaNeT-2/MATISSE RCT showed that a liberal threshold of 50,000/µL was associated with significantly higher death and major bleeding compared to a restrictive threshold of 25,000/µL in preterm neonates. This shifted guidelines toward more conservative transfusion in non-bleeding stable neonates. (PMID: 37258776 - systematic review confirmation; Cortesi et al., Semin Fetal Neonatal Med 2025, PMID: 40089431)

Step 5 - FNAIT-Specific Management (if suspected)

Platelet Transfusion

• HPA-matched platelets are preferred (HPA-1a/5b negative units if available in UK/Australia)
• If HPA-matched not immediately available: do NOT delay - give random donor (unmatched) platelets
• Continued use of random donor platelets is acceptable if matched unavailable
• Monitor post-transfusion increments; repeated transfusions likely needed as HPA-mismatched platelets have short survival

IVIg

• Qualifying criteria for IVIg: Platelet count < 30,000/µL with suspected/confirmed FNAIT
• Dose: typically 1 g/kg IV
• Note: IVIg is unlikely to raise platelet counts for at least 24 hours after administration; adverse events include hemolysis
• At 45,000, IVIg is generally NOT indicated unless count is falling rapidly toward <30,000 or there is active bleeding

Monitoring

• Daily platelet counts until stable and trending upward
• Repeat cranial ultrasound if initially abnormal or clinical deterioration
• Thrombocytopenia from FNAIT typically lasts 1-6 weeks after birth

Step 6 - Additional Measures

• Minimize invasive procedures (avoid IM injections, lumbar puncture if count is falling)
• Avoid drugs that impair platelet function (e.g., indomethacin, aspirin)
• Avoid intramuscular injections until platelet count >50,000
• Vitamin K - ensure given (usually oral at this platelet level; IM if >50,000)
• Treat underlying cause: if sepsis is the driver, antibiotics take priority
• Maternal referral to high-risk obstetric service for future pregnancies if FNAIT confirmed

Summary Decision Algorithm for Day-1 Neonate with Platelets 45,000

Platelet 45,000 Day 1
       ↓
Is baby bleeding?
  YES → Transfuse immediately; aim > 50,000 (non-ICH) or > 100,000 (ICH)
  NO  ↓
Is FNAIT suspected (normal maternal platelet count, first baby/no prior workup)?
  YES → Cranial U/S, HPA typing, transfuse if <50,000 preterm or <30,000 term
  NO  ↓
Is baby preterm + sepsis/respiratory support?
  YES → Transfuse (at 30-50k threshold)
  NO → Monitor closely; repeat count in 12-24 hours; investigate cause

• Stanworth SJ & Mumford AD. "How I diagnose and treat neonatal thrombocytopenia." Blood 2023;141(22):2685-97 [PMID: 36810309-related]
• CAHS Neonatology Guideline: Thrombocytopenia (May 2024)
• Ribeiro et al. "Platelet transfusions in preterm infants: systematic review and meta-analysis." Eur J Pediatr 2023 [PMID: 37258776]
• Cortesi et al. "Platelet transfusion and bleeding risk." Semin Fetal Neonatal Med 2025 [PMID: 40089431]
• Creasy & Resnik's Maternal-Fetal Medicine, Chapter 53 (Fetal/Neonatal Alloimmune Thrombocytopenia)